[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"conditionNormalized\":\"airflow-obstruction\",\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:airflow-obstruction":25},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,1,0,[8],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":13,"acronym":14,"eligibilityCriteria":15,"healthyVolunteers":11,"sex":16,"minAge":17,"maxAge":4,"enrollmentInfo":18,"targetDuration":4,"studyType":21,"phases":4,"briefSummary":22,"conditions":23,"keywords":4,"overallStatus":26,"whyStopped":4,"lastUpdateSubmitDate":27,"lastUpdatePostDateStruct":28,"startDateStruct":31,"completionDateStruct":33,"leadSponsor":35,"locationsCount":4},"100640199","screening-for-obstructive-respiratory-disorders-in-the-general-population-during-the-mai-poumon-2026-prevention-campaign-prevalence-and-impact-on-the-care-pathway-100640199",false,"NCT07575880","Screening for Obstructive Respiratory Disorders in the General Population During the \"Mai Poumon 2026\" Prevention Campaign: Prevalence and Impact on the Care Pathway","Mai Poumons 26","* Inclusion criteria :\n* Age ≥ 18 years\n* Participating to the prevention campain \"Mai Poumons 2026\" on 09 Mai 2026\n* Exclusion criteria :\n* Contre-indication to perform a spirometry : hemoptysy, pneumothorax, myocardal infarction \\\u003C1month, thoracic anevrism, recent ophtalmologic, abdominal or thoracic surgery\n* Unable to perform a spirometry (understanding, coordination)\n* Patient under legal protection\n* Patient pregnant or breasting\n* Not affiliating to public healthcare\n* Patient deprived of liberty","ALL","18 Years",{"count":19,"type":20},200,"ESTIMATED","OBSERVATIONAL","Undiagnosed COPD represents a significant issue in terms of morbidity and mortality, as nearly 50% of smokers with chronic respiratory symptoms also experience impaired quality of life and acute events similar to COPD exacerbations. We aim to study the prevalence of airflow obstruction (AO) and PRISm (preserved ratio impaired spirometry) in the general population.",[24,25],"Chronic Obstructive Lung Disease","Airflow Obstruction","NOT_YET_RECRUITING","2026-05-11",{"date":29,"type":30},"2026-05-13","ACTUAL",{"date":32,"type":20},"2026-05-09",{"date":34,"type":20},"2026-12",{"name":36,"class":37},"Centre Hospitalier de la côte Basque","OTHER"]